BICO Group AB (publ) (OTCMKTS:CLLKF) Sees Significant Drop in Short Interest

BICO Group AB (publ) (OTCMKTS:CLLKF) was the recipient of a large decrease in short interest during the month of February. As of February 13th, there was short interest totaling 46 shares, a decrease of 96.5% from the January 29th total of 1,313 shares. Based on an average daily volume of 40 shares, the short-interest ratio is currently 1.2 days. Based on an average daily volume of 40 shares, the short-interest ratio is currently 1.2 days.

BICO Group AB (publ) Price Performance

Shares of BICO Group AB (publ) stock remained flat at C$2.03 during mid-day trading on Friday. The company’s stock had a trading volume of 225 shares, compared to its average volume of 1,936. BICO Group AB has a fifty-two week low of C$1.79 and a fifty-two week high of C$4.00. The company has a fifty day moving average price of C$2.06 and a 200-day moving average price of C$2.31.

About BICO Group AB (publ)

BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.

In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.